Genome Instability And DNA Damage Response In Lymphoid Malignancies | 9215
Journal of Clinical & Experimental Pathology
Like us on:
Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Lymphoid malignancies are characterized by the accumulation of DNA damage in the forms of point mutations, chromosomal
translocations, deletions, and numerical abnormalities. Evidence suggests that structural abnormalities, such as DNA:RNA
hybrids that form during faulty transcription or replication, serve as a trigger for genomic instability and checkpoint activation
which can lead to cell cycle arrest and apoptosis. We postulate that a subgroup of aggressive lymphoid malignancies escape
checkpoint activation through the upregulation of pathways and enzymes that can resolve these mutagenic abnormalities within
Here we investigate the occurrence of DNA:RNA hybrids in lymphomas and benign lymphoid lesions. We show that unlike
in benign lesions where DNA:RNA hybrid formation is frequent, DNA:RNA hybrids are relatively uncommon in a subset
highly proliferative lymphomas. Further, we demonstrate that RNASEH2A (the catalytic component of the human ribonuclease
H enzyme II which repairs DNA:RNA hybrids) is upregulated in this subset of predominantly aggressive lymphomas and
inversely correlates with checkpoint activation. We hypothesize that RNASEH2A acts as a non-oncogene addiction gene in these
malignancies, maintaining the survival of aggressive lymphomas in the setting of the increased cellular stress associated with the
tumorigenic state. Our findings provide new and the valuable tools for uncovering the potential novel targets in preventing and
treating the aggressive lymphoid malignancies.
Milena Vuica-Ross is an Assistant Professor of Pathology at Johns Hopkins School of Medicine. She received her Medical Doctorate and Masters in
Biomedicine from the School of Natural Sciences and Mathematics at the University of Zagreb, Croatia. She completed residency training program
in Pathology, as well as fellowships in Immunology, Molecular Biology, Genetics and Hematopathology at the Johns Hopkins School of Medicine.
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals